TRANSCEND CAPITAL ADVISORS, LLC iShares Biotechnology ETF Transaction History

TRANSCEND CAPITAL ADVISORS, LLC portfolio value:

$636,000
portfolio value

TRANSCEND CAPITAL ADVISORS, LLC quarter portfolio value change:

-0.57%
quarter

iShares Biotechnology ETF 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +26.07% 1.12K shares 129K $116.96 5.43K
Q2 2022 share Decrease -58.65% -6.11K shares -851K $117.63 4.31K
Q1 2022 share Decrease -0.10% -10 shares -235K $130.3 10.42K
Q4 2021 share Increase +0.35% 36 shares -71K $153.76 10.43K
Q3 2021 share Decrease -3.71% -401 shares -97K $161.68 10.39K
Q2 2021 share Increase +40.31% 3.10K shares 604K $163.53 10.8K
Q1 2021 share Decrease -2.91% -231 shares -44K $150.43 7.69K
Q4 2020 share Decrease -8.30% -718 shares 30K $151.22 7.92K
Q3 2020 share Increase 0.00% 8.64K shares 1.17M $135.12 8.64K
Q2 2020 share Decrease -100.00% -3.25K shares -351K $136.33 0
Q1 2020 share Increase 0.00% 3.25K shares 351K $107.35 3.25K